Girl hugging dog A brighter future for dogs with canine melanoma
 

Canine Oral Melanoma Treatment

Canine melanoma is traditionally treated with surgery and/or radiation therapy for the local tumor, surrounding tissues and local lymph nodes. Supporting therapy is often required to control the growth of distant (metastatic) cancer cells.1,2

Until recently, the most popular option for supporting therapy for many cancers was chemotherapy. But some cancers, such as canine melanoma, are known to be highly resistant to chemotherapy.2 In fact, chemotherapy may do little to prolong survival in cases of canine oral melanoma.1,2 This is why many researchers have focused on immunotherapy as a potential therapy for controlling the growth of tumor cells.

Recently, a therapeutic vaccine has become available on a limited basis. This vaccine is indicated for the treatment of dogs with stage II or stage III oral melanoma and for which local disease control has been achieved (negative local lymph nodes or positive lymph nodes that were surgically removed or irradiated).3

1Bergman PJ, et al. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 2006;24:4582-4585.
2Bergman PJ, et al. Long-Term Survival of Dogs with Advanced Malignant Melanoma after DNA Vaccination with Xenogeneic Human Tyrosinase: A Phase I Trial. Clinical Cancer Research 2003;9:1284-1290.
3Product label.

Merial Footprints


 
             
 
Our Products
 
Our Solutions
 
Our Services